3
Announcements
Trials
Browse
Landscape
Sponsor
Conditions
Prostatic Neoplasms
4
Breast Neoplasms
3
Vulvar Neoplasms
1
Vulvar Diseases
1
Uterine Cervical Dysplasia
1
Triple Negative Breast Neoplasms
1
Toxemia
1
Stomach Neoplasms
1
Sarcoma
1
Rhabdomyosarcoma
1
Rectal Neoplasms
1
Primary Ovarian Insufficiency
1
Precursor Cell Lymphoblastic Leukemia-Lymphoma
1
Polycystic Ovary Syndrome
1
Papillomavirus Infections
1
Pancreatic Neoplasms
1
Neuroendocrine Tumors
1
Neoplasms
1
Myocarditis
1
Muscle Weakness
1
Melanoma
1
Hematologic Neoplasms
1
Gastrointestinal Neoplasms
1
Diabetes, Gestational
1
Colonic Neoplasms
1
Cardiovascular Diseases
1
Carcinoma, Neuroendocrine
1
Carcinoma in Situ
1
Brain Neoplasms
1
Adenocarcinoma
1
Interventions
Rituximab
27
Lenalidomide
22
Cyclophosphamide
20
Prednisone
14
Vincristine
12
obinutuzumab
11
Magnetic Resonance Spectroscopy
11
Doxorubicin
11
Specimen Handling
9
Bendamustine Hydrochloride
8
ibrutinib
7
Biopsy
7
pembrolizumab
6
fludarabine
6
fludarabine phosphate
5
Radiotherapy
5
Peripheral Blood Stem Cell Transplantation
5
zanubrutinib
4
venetoclax
4
tazemetostat
4
Whole-Body Irradiation
4
R-CHOP protocol
4
Etoposide
4
CT-P10
4
Prednisolone
3
Mycophenolic Acid
3
Cyclosporine
3
tisagenlecleucel
2
polatuzumab vedotin
2
orelabrutinib
2
Date Range
30 days
90 days
1 year
All
Options
Has results
Has announcements
Clinical Trials
0 trials
Recent
Start date
Enrollment
Lymphoma, Follicular
×
Positron-Emission Tomography
×
90 days
×
Clear all
No trials found.